Susan Wills, INSIGHTEC’s country manager for the UK and Ireland, said: “MRgFUS has the potential to improve the quality of healthcare treatments to patients and to minimise the trauma to the patient and their families, whilst accelerating their recovery and saving costs for the healthcare system. It is exciting to be working with Red Lorry Yellow Lorry in order to educate patients and providers on the benefits of this new treatment alternative and to help accelerate the adoption of MRgFUS to make a change to millions of lives.”
The MRgFUS platform uses focused ultrasound waves to safely ablate targeted tissue. The non-invasive therapy can be used to treat a variety of neurological, oncological and gynaecological conditions.
Guy Walsingham, managing director at Red Lorry Yellow Lorry, said: “INSIGHTEC’s innovative Exablate platform pushes the boundaries of what is possible in medical technology, to give patients more treatment options. We’re very proud to be working with a company that’s at the forefront of its industry and highlighting the amazing work they’re doing in treating these conditions.”